Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets

Published

on

Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets
Shares of Concord Biotech rose over 6% to their day’s high of Rs 1,350 on the BSE on Wednesday after the company announced that it had received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Tofacitinib Tablets in 5 mg and 10 mg strengths.

According to the company, the approval covers Tofacitinib Tablets indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis (PsA), active ankylosing spondylitis (AS), moderately to severely active ulcerative colitis (UC), active PsA, and active polyarticular course juvenile idiopathic arthritis (pcJIA).

The regulatory approval has been granted by the U.S. Food and Drug Administration, the company said in its filing. Concord Biotech stated that the approval aligns with its growth strategy and is expected to strengthen its position in the U.S. market. The company added that the clearance allows it to expand its product portfolio and pursue opportunities in the U.S. and international markets.

According to market estimates cited by the company, the U.S. market opportunity for Tofacitinib Tablets across the 5 mg and 10 mg strengths is approximately $500 million. The approval pertains specifically to the company’s ANDA for Tofacitinib Tablets in the two approved dosage strengths. The company said the development supports its long-term growth plans and enhances its ability to participate in the relevant therapeutic segments in the United States.

Advertisement

The company noted that the approval for Tofacitinib Tablets, 5 mg and 10 mg, is expected to strengthen its presence in the U.S. market while broadening its range of offerings. The approval also provides access to a market that the company estimates at approximately $500 million for the two strengths combined.

Concord Q4 snapshot

The R&D-focused biopharmaceutical company reported a 36.8% year-on-year decline in fourth-quarter net profit at Rs 88.8 crore, compared with Rs 140.4 crore in the corresponding period last year, as lower revenue and margin compression weighed on earnings.
Revenue from operations fell 24.1% to Rs 326.1 crore from Rs 429.9 crore a year earlier. EBITDA for the quarter declined 37.8% year-on-year to Rs 118.5 crore, while the EBITDA margin contracted to 36.4% from 44.3% in the year-ago quarter.
Concord share price is down 36% in the last 1 year. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Tracking Philippe Laffont's Coatue Management Portfolio – Q1 2026 Update

Published

on

Tracking Philippe Laffont's Coatue Management Portfolio - Q1 2026 Update

Tracking Philippe Laffont's Coatue Management Portfolio – Q1 2026 Update

Continue Reading

Business

Best Dividend Kings: July 2026

Published

on

Top 25 High-Yield Dividend Stocks For April 2026

This article was written by

I have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoughts with the Seeking Alpha community.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABBV, ADP, HRL, JNJ, LOW, PEP, SPGI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Brown-Forman board says Sazerac unsolicited proposal not actionable

Published

on


Brown-Forman board says Sazerac unsolicited proposal not actionable

Continue Reading

Business

Tracking Lone Pine Capital Portfolio – Q1 2026 Update

Published

on

Tracking The $13.61B Lone Pine Capital Portfolio - Q4 2025 Update

Tracking Lone Pine Capital Portfolio – Q1 2026 Update

Continue Reading

Business

Banco Santander, S.A. 2026 Q2 – Results – Earnings Call Presentation (NYSE:SAN) 2026-07-26

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Chipotle opens first Mexico location as it plans further expansion

Published

on

Chipotle opens first Mexico location as it plans further expansion

Chipotle Mexican Grill opened its first restaurant in Mexico this month as part of the fast-casual chain’s international growth strategy.

The new location opened on July 16 in San Pedro Garza García, Nuevo León, part of the Monterrey metropolitan area, and is being operated in partnership with restaurant operator Alsea, according to a news release from Chipotle.

Advertisement

“We are entering Mexico with deep respect for the country’s culinary heritage and a commitment to delivering the Chipotle experience with excellence,” Scott Boatwright, CEO of Chipotle, said in a statement. 

“Our research has reinforced our belief that there is strong interest in high-quality, freshly prepared food served with the customization and convenience that Chipotle offers.”

CHIPOTLE RIVAL GUZMAN Y GOMEZ MEXICAN KITCHEN CLOSES ALL US RESTAURANTS

Chipotle Mexican Grill opened its first restaurant in Mexico this month as part of the fast-casual chain's international growth strategy.

Chipotle Mexican Grill opened its first restaurant in Mexico this month as part of the fast-casual chain’s international growth strategy. (Chipotle)

Chipotle and Alsea plan to open additional locations in Nuevo León later this year, followed by an expansion into Mexico City in 2027. 

Advertisement

The restaurant is the first to open under a development agreement the companies announced in April 2025.

Alsea runs several thousand restaurants from global quick-service, coffee shop and full-service brands in many countries in Latin America and Europe, according to Chipotle.

CHIPOTLE CEO ALLEGEDLY SUGGESTS COMPANY WOULD KEEP RAISING PRICES AND ‘LEAN INTO’ CUSTOMERS MAKING OVER $100K

Chipotle Mexican Grill opened its first restaurant in Mexico this month as part of the fast-casual chain's international growth strategy.

The new location opened on July 16 in San Pedro Garza García, Nuevo León. (Chipotle)

The new restaurant offers Chipotle’s standard menu of customizable burritos, bowls, tacos, salads and quesadillas. Many ingredients are sourced from regional suppliers, according to the company.

Advertisement

Chipotle said the Monterrey area was selected because of its “strong economy, growing population” and position as a major business hub. 

“Bringing Chipotle to Mexico is an important step in our growth and portfolio diversification strategy,” Christian Gurría, CEO of Alsea, said in a statement. “We are introducing an iconic brand with a differentiated value proposition that has resonated with millions of guests around the world, and we are confident it will be warmly welcomed by Mexican consumers.”

Stocks In This Article:

CHIPOTLE TO OPEN MEXICAN LOCATIONS FOR THE FIRST TIME IN 2026

A customer dines inside a Chipotle restaurant

As of March 31, Chipotle operated more than 4,100 restaurants worldwide. (David Paul Morris/Bloomberg via Getty Images)

As of March 31, Chipotle operated more than 4,100 restaurants worldwide.

Advertisement

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The restaurant chain expects to open between 350 and 370 new locations in 2026. Its international footprint includes restaurants in Canada, Europe and the Middle East, with additional openings planned in South Korea and Singapore.

Chipotle could not immediately be reached by FOX Business for additional comment.

FOX Business’ Aislinn Murphy contributed to this report.

Advertisement
Continue Reading

Business

Exclusive | Sazerac Wants Another Shot at Jack Daniel’s Maker Brown-Forman

Published

on

Exclusive | Sazerac Wants Another Shot at Jack Daniel’s Maker Brown-Forman

Sazerac isn’t taking no for an answer.

The maker of BuzzBallz cocktails and Buffalo Trace bourbon has sent a letter to a group of Brown-Forman BF.B shareholders asking them to reconsider a $15 billion buyout offer that had been rebuffed. The group—Class A shareholders—includes members of the Brown family, descendants of the company’s founder who currently control its voting power.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Oil slips more than 5% after US pauses strikes on Iran

Published

on


Oil slips more than 5% after US pauses strikes on Iran

Continue Reading

Business

Are Midterm Elections a headwind for stocks?

Published

on


Are Midterm Elections a headwind for stocks?

Continue Reading

Business

Thailand Food Supplement Market to Reach US$ 2.52B by 2033

Published

on

Thailand Food Supplement Market to Reach US$ 2.52B by 2033

The Thailand Food Supplement Market is projected to grow from US$2.02 billion in 2023 to US$2.52 billion by 2033, driven by health awareness, an aging population, and rising demand for nutritional products.


The Thailand Food Supplement Market is on an upward trajectory, anticipated to grow from approximately USD 2.02 billion in 2025 to USD 2.52 billion by 2033, maintaining a CAGR of 5.90%. This growth is fueled by rising health consciousness, a shift towards preventive healthcare, and increasing interest in nutritional supplements. Consumers are keen on products that enhance overall wellness, immune function, weight management, and beauty.

The market’s expansion further benefits from an aging population, which drives demand for supplements targeting chronic conditions. There is a notable cultural inclination towards natural and herbal ingredients, integrating traditional Thai medicine into mainstream products. E-commerce platforms and pharmacy channels are also enhancing accessibility to these health products.

Key players such as H MEGA Lifesciences and Giffarine Skyline Unity are addressing local preferences by offering diverse nutritional supplements. The focus on plant-based formulations and personalized nutrition is transforming the market landscape. Companies are strategically leveraging innovations and collaborations to cater to a health-conscious consumer base, ensuring continued growth in Thailand’s vibrant wellness industry.

Advertisement

Continue Reading

Trending

Copyright © 2025